Swiss National Bank Has $263.60 Million Stock Position in CVS Health Corporation $CVS

Swiss National Bank grew its holdings in CVS Health Corporation (NYSE:CVS) by 7.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,821,360 shares of the pharmacy operator’s stock after purchasing an additional 272,100 shares during the period. Swiss National Bank owned approximately 0.30% of CVS Health worth $263,597,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Avion Wealth raised its stake in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. bought a new position in CVS Health in the 2nd quarter valued at approximately $30,000. Bell Investment Advisors Inc boosted its position in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares in the last quarter. Roxbury Financial LLC grew its stake in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares during the last quarter. Finally, ORG Partners LLC increased its holdings in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Up 2.5%

CVS stock opened at $77.92 on Friday. The firm has a market capitalization of $98.91 billion, a PE ratio of 205.06, a P/E/G ratio of 0.87 and a beta of 0.60. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The stock’s 50 day moving average is $78.12 and its 200-day moving average is $70.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the prior year, the company posted $1.09 earnings per share. CVS Health’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s dividend payout ratio is currently 700.00%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CVS. Leerink Partners raised their price objective on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 16th. Zacks Research lowered CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Royal Bank Of Canada boosted their target price on shares of CVS Health from $81.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Jefferies Financial Group increased their target price on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Finally, Wells Fargo & Company decreased their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.41.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.